Literature DB >> 19634326

Globulixanthone F, a new polyoxygenated xanthone with an isoprenoid group and two antimicrobial biflavonoids from the stem bark of Symphonia globulifera.

Pierre Mkounga1, Zacharias T Fomum, Michèle Meyer, Bernard Bodo, Augustin E Nkengfack.   

Abstract

Bioassay-guided fractionation of the stem bark of Symphonia globulifera has yielded three known xanthones, ugaxanthone (1), mbarraxanthone (2) and gentisein (3), two biflavonoid derivatives named GB2 (4) and manniflavanone GB3 (5), and one new polyoxygenated xanthone with an isoprenoid group, named globulixanthone F (6). The structures of these compounds were elucidated by means of spectroscopic methods. The spectral data of 1 and 2 are reported here for the first time, as well as the antimicrobial activity of globulixanthone F against a range of microorganisms. We also report the total synthesis of the xanthone skeleton.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634326

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  3 in total

1.  In vitro activity of Amazon plant extracts against Enterococcus faecalis.

Authors:  Adriana Lígia de Castilho; Juliana Paola Correa da Silva; Cintia Helena Coury Saraceni; Ingrit Elida Collantes Díaz; Mateus Luís Barradas Paciencia; Antonio Drauzio Varella; Ivana Barbosa Suffredini
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

2.  Phytochemical profile and antimicrobial activity of the leaves and stem bark of Symphonia globulifera L.f. and Allophylus abyssinicus (Hochst.) Radlk.

Authors:  Ben Lukubye; Clement Olusoji Ajayi; Rapheal Wangalwa; Grace Kagoro-Rugunda
Journal:  BMC Complement Med Ther       Date:  2022-08-23

3.  Mice Behavioral Phenotype Changes after Administration of Anani (Symphonia globulifera, Clusiaceae), an Alternative Latin American and African Medicine.

Authors:  Ivana Barbosa Suffredini; Mateus Luís Barradas Paciencia; Ingrit E C Díaz; Sergio Alexandre Frana; Maria Martha Bernardi
Journal:  Pharmacogn Mag       Date:  2017-11-13       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.